Genetic products which are differentially expressed in tumors and use thereof

Details for Australian Patent Application No. 2011218666 (hide)

Owner Ganymed Pharmaceuticals AG

Inventors Koslowski, Michael; Sahin, Ugur; Tureci, Ozlem

Agent Phillips Ormonde Fitzpatrick

Pub. Number AU-A-2011218666

Parent 2004272270

Filing date 30 August 2011

Wipo publication date 15 September 2011

International Classifications

C07K 14/47 (2006.01) Peptides having more than 20 amino acids

C07K 16/30 (2006.01) Immunoglobulins, e.g. monoclonal or polyclonal antibodies

C12Q 1/68 (2006.01) Measuring or testing processes involving enzymes or micro-organisms - involving nucleic acids

Event Publications

15 September 2011 Application Open to Public Inspection

  Published as AU-A-2011218666

15 September 2011 Complete Application Filed

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2011218667-Cheese products with enhanced melt and methods

2011218665-Production of canola protein